Venue: Hong Kong

Location: Hong Kong, Hong Kong

Event Date/Time: Sep 12, 2011 End Date/Time: Sep 14, 2011
Report as Spam


Navigate the CDx space in Asia

The pharmaceutical industry in Asia is experiencing unprecedented growth right now and there’s a huge patient population base and untapped market in need of tailored therapeutics. There’s huge opportunity to be found here for the companies who understand this marketplace.
But when it comes to the practicalities of developing and commercializing a personalized therapeutic in Asia, there are some unique challenges you need to be aware of. This event will serve as Asia’s only global meeting place for biomarker, diagnostic and commercial experts to focus exclusively on how to seize this near term opportunity to deliver better, safer drugs to the Asian market with drug-diagnostic co-development.
What will you learn?
The World Companion Diagnostics Summit Asia is the perfect place to meet drug and diagnostic industry leaders to learn the latest approaches to turn biomarker research into successful patient stratification. Here are just some of the topics we’ll be addressing:
• The different CDx strategies companies are taking, both in large pharma and smaller drug developing companies: How are they going about trying to stratify patient populations?
• What do the regulatory and commercial hurdles look like for companion diagnostics in the Asian marketplace? How will reimbursement work?
• How will companion diagnostic deals and partnerships play out in the Asian market place? What do the business models looks like?
• How do you identify the critical predictive markers early on in drug development and what are the latest tools and technologies for molecular profiling as we move away from genetics?
• How do we translate biomarkers from the laboratory to the clinic and achieve assay validation?
• Who has run or is looking to run their clinical trial based on a biomarker, and how are companies thinking about when and how to develop a diagnostic test?

Why attend?
• Every presentation and contact will help you improve your research and business aims - everyone at the meeting is here to discuss how to turn biomarker research into patient stratification and to deliver better, safer drugs to the Asian market with drug-diagnostic co-development.
• Don't just listen to speakers and attendees - meet them and discuss your work in our intimate and informal conference setting. Plus, we'll make sure you meet everybody you want to in our dedicated speed networking session.
• Receive tailored guidance on achieving patient stratification - our pre-conference workshops are a fantastic opportunity to get the information and contacts you need to achieve your research and business aims (over and above the inside information you will gain from the meeting itself).

Who's this meeting for?
Whether you are new to the field or expanding your existing capabilities around biomarker development and companion diagnostics, this meeting is a one-stop shop of the latest developments and strategies you need to be aware of. That means anyone involved with:
• Biomarkers
• (Companion) diagnostics
• Molecular profiling
• Pharmacogenomics/pharmacogenetics
• Translational medicine
• Personalized medicine
• Clinical development
• Regulatory affairs
• Strategy and portfolio management
• Commercial/business development

To register simply:
Call: +44 20 3141 8700

Please quote the booking code: LIST when registering to secure your place at the meeting.